Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Bladder Cancer

Free Subscription 20.02.2023 1 Am J Cancer Res 1 Am J Clin Nutr 1 Ann Surg Oncol 1 Biom J 1 bioRxiv 1 BMC Urol 1 Cancer Biomark 1 Cancer Res 8 Cancers (Basel) 1 Cell Death Dis 1 Cells 1 Cent European J Urol 1 Chem Biol Drug Des 1 Clin Cancer Res 1 Clin Genitourin Cancer 1 Drug Resist Updat 1 EMBO J 1 Eur J Radiol 2 Eur Urol Oncol 1 Expert Opin Pharmacother 1 Front Genet 3 Front Immunol 1 Front Oncol 1 Future Sci OA 1 Gan To Kagaku Ryoho 1 Int J Environ Res Public Health 3 Int J Mol Sci 1 Int J Surg 2 Int J Urol 1 J Fluoresc 1 J Laparoendosc Adv Surg Tech A 2 J Transl Med 6 J Urol 2 Lab Invest 1 Med Ultrason 1 Mod Pathol 1 Oncologist 1 Pediatr Int 1 Saudi J Biol Sci 1 Scott Med J 3 Urol Oncol 1 Urologie 5 Urology 1 Zhonghua Zhong Liu Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cancer Res

1. DE SOUZA AL, Mega AE, Douglass J, Olszewski AJ, et al
   Clinical features of patients with MTAP-deleted bladder cancer.
   Am J Cancer Res. 2023;13:326-339.
   PubMed         Abstract available
   
   

   
   Am J Clin Nutr

2. VAN ZUTPHEN M, Hof JP, Aben KK, Kampman E, et al
   Adherence to lifestyle recommendations after non-muscle invasive bladder cancer diagnosis and risk of recurrence.
   Am J Clin Nutr. 2023 Feb 11:S0002-9165(23)04155.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

3. AMINOLTEJARI K, Hird AE, Klaassen Z, Satkunasivam R, et al
   Robotic Versus Open Cystectomy for Bladder Cancer: Synthesizing the Data from Current Systematic Reviews and Meta-Analyses.
   Ann Surg Oncol. 2023 Feb 11. doi: 10.1245/s10434-022-12692.
   PubMed         Abstract available
   
   

   
   Biom J

4. SUN H, Wang X
   High-dimensional feature selection in competing risks modeling: A stable approach using a split-and-merge ensemble algorithm.
   Biom J. 2023;65:e2100164.
   PubMed         Abstract available
   
   

   
   bioRxiv

5. WONG JL, Smith P, Angulo-Lozano J, Ranti D, et al
   IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer.
   bioRxiv. 2023 Feb 1:2023.01.30.526266. doi: 10.1101/2023.01.30.526266.
   PubMed         Abstract available
   
   

   
   BMC Urol

6. LIU P, Xu L, Chen G, Shi B, et al
   Nomograms for predicting survival in patients with micropapillary bladder cancer: a real-world analysis based on the surveillance, epidemiology, and end results database and external validation in a tertiary center.
   BMC Urol. 2023;23:16.
   PubMed         Abstract available
   
   

   
   Cancer Biomark

7. MOLLER K, Knoll M, Bady E, Schmerder MJ, et al
   PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples.
   Cancer Biomark. 2023;36:177-191.
   PubMed         Abstract available
   
   

   
   Cancer Res

8. CASWELL D, Swanton C
   Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer.
   Cancer Res. 2023;83:487-488.
   PubMed         Abstract available
   
   

   
   Cancers (Basel)

9. KAMECKI H, Debowska M, Poleszczuk J, Demkow T, et al
   Incidental Diagnosis of Urothelial Bladder Cancer: Associations with Overall Survival.
   Cancers (Basel). 2023;15:668.
   PubMed         Abstract available
   
   
10. LIU J, Zhou Z, Jiang Y, Lin Y, et al
    EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer.
    Cancers (Basel). 2023;15:621.
    PubMed         Abstract available
    
    
11. LEONARDO C, Flammia RS, Lucciola S, Proietti F, et al
    Performance of Node-RADS Scoring System for a Standardized Assessment of Regional Lymph Nodes in Bladder Cancer Patients.
    Cancers (Basel). 2023;15:580.
    PubMed         Abstract available
    
    
12. PAPAVASILIOU E, Sills VA, Calanzani N, Harrison H, et al
    Diagnostic Performance of Biomarkers for Bladder Cancer Detection Suitable for Community and Primary Care Settings: A Systematic Review and Meta-Analysis.
    Cancers (Basel). 2023;15:709.
    PubMed         Abstract available
    
    
13. ZHANG Y, Wang W, Zhou H, Cui Y, et al
    Urinary Eubacterium sp. CAG:581 Promotes Non-Muscle Invasive Bladder Cancer (NMIBC) Development through the ECM1/MMP9 Pathway.
    Cancers (Basel). 2023;15:809.
    PubMed         Abstract available
    
    
14. AFONSO J, Goncalves C, Costa M, Ferreira D, et al
    Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy.
    Cancers (Basel). 2023;15:982.
    PubMed         Abstract available
    
    
15. ESTEBAN-VILLARRUBIA J, Torres-Jimenez J, Bueno-Bravo C, Garcia-Mondaray R, et al
    Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2023;15:566.
    PubMed         Abstract available
    
    
16. PAPPOT H, Ullen A
    Optimal Systemic Treatment of Advanced Bladder Cancer Calls for a Multidisciplinary Approach.
    Cancers (Basel). 2023;15:559.
    PubMed         Abstract available
    
    

    
    Cell Death Dis

17. ZHANG Z, Mou Z, Xu C, Wu S, et al
    Correction: Autophagy-associated circular RNA hsa_circ_0007813 modulates human bladder cancer progression via hsa-miR-361-3p/IGF2R regulation.
    Cell Death Dis. 2023;14:113.
    PubMed        
    
    

    
    Cells

18. KOWALD S, Huge Y, Tandiono D, Ali Z, et al
    Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer.
    Cells. 2023;12:508.
    PubMed         Abstract available
    
    

    
    Cent European J Urol

19. TAPPERO S, Sorce G, Panunzio A, Hohenhorst L, et al
    Efficacy of chemotherapy on overall survival in metastatic sarcomatoid bladder cancer patients.
    Cent European J Urol. 2022;75:352-356.
    PubMed         Abstract available
    
    

    
    Chem Biol Drug Des

20. YANG Z, Bi Y, Xu W, Guo R, et al
    Glabridin inhibits urothelial bladder carcinoma cell growth in vitro and in vivo by inducing cell apoptosis and cell cycle arrest.
    Chem Biol Drug Des. 2023;101:581-592.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

21. CHRISTENSEN E, Nordentoft I, Birkenkamp-Demtroder K, Elbaek SK, et al
    Cell-free urine- and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle invasive bladder cancer.
    Clin Cancer Res. 2023 Feb 13:CCR-22-3250. doi: 10.1158/1078-0432.CCR-22-3250.
    PubMed         Abstract available
    
    

    
    Clin Genitourin Cancer

22. VON DEIMLING M, Schuettfort VM, D'Andrea D, Pradere B, et al
    Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy.
    Clin Genitourin Cancer. 2023 Jan 26:S1558-7673(23)00031.
    PubMed         Abstract available
    
    

    
    Drug Resist Updat

23. LI F, Zheng Z, Chen W, Li D, et al
    Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms.
    Drug Resist Updat. 2023;68:100938.
    PubMed         Abstract available
    
    

    
    EMBO J

24. SHIGETA K, Hasegawa M, Hishiki T, Naito Y, et al
    IDH2 stabilizes HIF-1alpha-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer.
    EMBO J. 2023;42:e110620.
    PubMed         Abstract available
    
    

    
    Eur J Radiol

25. TSILI AC, Varkarakis I, Pasoglou V, Anagnostou N, et al
    CT of the urinary tract revisited.
    Eur J Radiol. 2023;160:110717.
    PubMed         Abstract available
    
    

    
    Eur Urol Oncol

26. ARITA Y, Yoshida S, Shigeta K, Kwee TC, et al
    Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology.
    Eur Urol Oncol. 2023;6:99-102.
    PubMed         Abstract available
    
    
27. HUYNH MA, Tang C, Siva S, Berlin A, et al
    Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers.
    Eur Urol Oncol. 2023;6:28-38.
    PubMed         Abstract available
    
    

    
    Expert Opin Pharmacother

28. BIANCHI A, von Deimling M, Pallauf M, Yanagisawa T, et al
    Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond.
    Expert Opin Pharmacother. 2023;24:177-195.
    PubMed         Abstract available
    
    

    
    Front Genet

29. LI S, Jiang M, Yang L, Zheng F, et al
    Identification of platinum resistance-related gene signature for prognosis and immune analysis in bladder cancer.
    Front Genet. 2023;14:1062060.
    PubMed         Abstract available
    
    

    
    Front Immunol

30. KIMURA Y, Fujimori M, Rajagopalan NR, Poudel K, et al
    Macrophage activity at the site of tumor ablation can promote murine urothelial cancer via transforming growth factor-beta1.
    Front Immunol. 2023;14:1070196.
    PubMed         Abstract available
    
    
31. LOPES S, Pabst L, Dory A, Klotz M, et al
    Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis.
    Front Immunol. 2023;14:1070076.
    PubMed         Abstract available
    
    
32. SUN Z, Jing C, Zhan H, Guo X, et al
    Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine.
    Front Immunol. 2023;14:1097472.
    PubMed         Abstract available
    
    

    
    Front Oncol

33. YANG Y, Wang C, Li Z, Lu Q, et al
    Precise diagnosis and treatment of non-muscle invasive bladder cancer - A clinical perspective.
    Front Oncol. 2023;13:1042552.
    PubMed         Abstract available
    
    

    
    Future Sci OA

34. AL-ZUBI MT, Demour SA, Al-Rawashdah SF, Carbone A, et al
    Does post-void residual urine volume affect potential recurrence risk for non-muscle invasive bladder cancer?
    Future Sci OA. 2023;8:FSO823.
    PubMed         Abstract available
    
    

    
    Gan To Kagaku Ryoho

35. HATAKEYAMA S, Ohyama C
    [Ⅱ. Update on Guideline for Management of Metastatic Urothelial Carcinoma].
    Gan To Kagaku Ryoho. 2023;50:45-49.
    PubMed        
    
    

    
    Int J Environ Res Public Health

36. HAGHAYEGH S, Liu Y, Zhang Y, Strohmaier S, et al
    Rotating Night Shift Work and Bladder Cancer Risk in Women: Results of Two Prospective Cohort Studies.
    Int J Environ Res Public Health. 2023;20:2202.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

37. TERANISHI K
    In Vivo Optical Imaging of Bladder Cancer Tissues in an MB49 Bladder Cancer Orthotopic Mouse Model Using the Intravesical or Intravenous Administration of Near-Infrared Fluorescence Probe.
    Int J Mol Sci. 2023;24:2349.
    PubMed         Abstract available
    
    
38. GIANNIOU DD, Sklirou AD, Papadimitriou MA, Pilala KM, et al
    Evaluation of the Small Heat Shock Protein Family Members HSPB2 and HSPB3 in Bladder Cancer Prognosis and Progression.
    Int J Mol Sci. 2023;24:2609.
    PubMed         Abstract available
    
    
39. ZHENG Q, Jiang Z, Ni X, Yang S, et al
    Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer.
    Int J Mol Sci. 2023;24:2746.
    PubMed         Abstract available
    
    

    
    Int J Surg

40. TAN Z, Wang H, Wang J
    A commentary on 'systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer' (Int J S
    Int J Surg. 2023;109:208-210.
    PubMed        
    
    

    
    Int J Urol

41. MIYAMOTO T, Miyake M, Nakahama T, Nishimura N, et al
    Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non-muscle invasive bladder cancer: A multi-institutional collaborative study.
    Int J Urol. 2023 Feb 14. doi: 10.1111/iju.15162.
    PubMed         Abstract available
    
    
42. YANG H, Zhang Z, Zhao K, Zhang Y, et al
    Initial experience with 161 extraperitoneal laparoscopic radical cystectomy procedures: Comparison with transabdominal laparoscopic radical cystectomy.
    Int J Urol. 2023;30:155-160.
    PubMed         Abstract available
    
    

    
    J Fluoresc

43. MALEK-ESFANDIARI Z, Rezvani-Noghani A, Sohrabi T, Mokaberi P, et al
    Molecular Dynamics and Multi-Spectroscopic of the Interaction Behavior between Bladder Cancer Cells and Calf Thymus DNA with Rebeccamycin: Apoptosis through the Down Regulation of PI3K/AKT Signaling Pathway.
    J Fluoresc. 2023 Feb 14. doi: 10.1007/s10895-023-03169.
    PubMed         Abstract available
    
    

    
    J Laparoendosc Adv Surg Tech A

44. TUO Z, Wang J, Zhang Y, Bi L, et al
    Learning Curve of a Novel Three-Port Laparoscopic Radical Cystectomy with Urinary Diversion: A Single-Center Retrospective Analysis.
    J Laparoendosc Adv Surg Tech A. 2023;33:188-193.
    PubMed         Abstract available
    
    

    
    J Transl Med

45. GANJI M, Bakhshi S, Shoari A, Ahangari Cohan R, et al
    Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer.
    J Transl Med. 2023;21:111.
    PubMed         Abstract available
    
    
46. KOLL FJ, Banek S, Kluth L, Kollermann J, et al
    Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis.
    J Transl Med. 2023;21:124.
    PubMed         Abstract available
    
    

    
    J Urol

47. MYERS A, Frank I, Shah PH, Tarrell RF, et al
    Intraoperative Blood Transfusion Is Associated With Increased Risk of Venous Thromboembolism After Radical Cystectomy.
    J Urol. 2023;209:525-531.
    PubMed         Abstract available
    
    
48. PALLAUF M, D'Andrea D, Konig F, Laukhtina E, et al
    Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study.
    J Urol. 2023;209:515-524.
    PubMed         Abstract available
    
    
49. TISSOT G, Xylinas E
    Lymph Node Dissection in Upper Tract Urothelial Cancer: Ready for Prime Time?
    J Urol. 2023;209:462-463.
    PubMed        
    
    
50. MASTROIANNI R, Ochoa Arvizo MA, Torregiani G, Simone G, et al
    Robot-assisted vs Open Radical Cystectomy: Randomized Controlled Trials Lights and Shadows.
    J Urol. 2023;209:460-461.
    PubMed        
    
    
51. VANDEN BERG RNW, Abern M
    National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. Letter.
    J Urol. 2023;209:508.
    PubMed        
    
    
52. PRUNTY M, Shoag J
    National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. Reply.
    J Urol. 2023;209:508-509.
    PubMed        
    
    

    
    Lab Invest

53. SHAFI S, Aung TN, Xirou V, Gavrielatou N, et al
    Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer.
    Lab Invest. 2022;102:1143-1149.
    PubMed         Abstract available
    
    
54. WANG L, Wu S, He H, Ai K, et al
    CircRNA-ST6GALNAC6 increases the sensitivity of bladder cancer cells to erastin-induced ferroptosis by regulating the HSPB1/P38 axis.
    Lab Invest. 2022;102:1323-1334.
    PubMed         Abstract available
    
    

    
    Med Ultrason

55. ZHU J, Huang X, Liu L, Wang N, et al
    Can the Vesical Imaging Reporting and Data System (VI-RADS) score be applied in conventional ultrasound and contrast-enhanced ultrasound to differentiate muscle-invasive bladder cancer?
    Med Ultrason. 2023 Feb 7. doi: 10.11152/mu-3841.
    PubMed         Abstract available
    
    

    
    Mod Pathol

56. ACOSTA AM, Demicco EG, Dal Cin P, Hirsch MS, et al
    Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions.
    Mod Pathol. 2021;34:469-477.
    PubMed         Abstract available
    
    

    
    Oncologist

57. JARDIM DLF, Millis SZ, Ross JS, Lippman S, et al
    Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors.
    Oncologist. 2023;28:e82-e91.
    PubMed         Abstract available
    
    

    
    Pediatr Int

58. MOMO OM, Otake S, Minamikawa S, Ohkusu K, et al
    Painless subcutaneous abscess caused by bacillus Calmette-Guerin osteomyelitis.
    Pediatr Int. 2023;65:e15381.
    PubMed        
    
    

    
    Saudi J Biol Sci

59. SEVIM NALKIRAN H, Akcora Yildiz D, Saydam F, Guzel AI, et al
    Targeting the anaphase-promoting complex/cyclosome (APC/C) enhanced antiproliferative and apoptotic response in bladder cancer.
    Saudi J Biol Sci. 2023;30:103564.
    PubMed         Abstract available
    
    

    
    Scott Med J

60. ANBARASAN T, Nissar S, Turbitt J, Walls K, et al
    Urinary bladder recurrences following ureteroscopic biopsies of upper tract urothelial cancers: a multi-centre observational study with genomic assessment for clonality.
    Scott Med J. 2023;68:4-13.
    PubMed         Abstract available
    
    

    
    Urol Oncol

61. SMELSER WW, Tallman JE, Gupta VK, Al Hussein Al Awamlh B, et al
    Implementation of a comprehensive prehabilitation program for patients undergoing radical cystectomy.
    Urol Oncol. 2023;41:108.
    PubMed         Abstract available
    
    
62. ALSYOUF M, Ladi-Seyedian SS, Konety B, Pohar K, et al
    Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?
    Urol Oncol. 2023;41:109.
    PubMed         Abstract available
    
    
63. RAHMAN SN, Lokeshwar SD, Syed JS, Javier-Desloges JF, et al
    Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder.
    Urol Oncol. 2023;41:107.
    PubMed         Abstract available
    
    

    
    Urologie

64. YIRGA L, Hadaschik B, Burger M, Pullen L, et al
    [Photodynamic TUR-B: it looks better than it is : Comment on the randomized study].
    Urologie. 2023;62:181-183.
    PubMed        
    
    

    
    Urology

65. ALSYOUF M, Daneshmand S
    Late Complication of Orthotopic T-Pouch Ileal Neobladder Diversion.
    Urology. 2023;172:e1-e2.
    PubMed        
    
    
66. MAKEDON AM, Sadowsky A, Johnson BA, Walker DT, et al
    A Novel Technique of Robotic-Assisted Simple Cystectomy During Urinary Diversion for Benign Indications.
    Urology. 2023;172:234.
    PubMed         Abstract available
    
    
67. BRITTON CJ, Gottlich HC, Tarrell RF, Thapa P, et al
    Perioperative and Oncologic Outcomes Associated with Simultaneous Radical Cystectomy and Nephroureterectomy.
    Urology. 2023;172:149-156.
    PubMed         Abstract available
    
    
68. SUBIELA JD, Gonzalez-Padilla DA, Huguet J, Aumatell J, et al
    Oncological and Renal Function Outcomes in Patients Who Underwent Simultaneous Radical Cystectomy and Nephroureterectomy for Synchronous or Metachronous Panurothelial Carcinoma.
    Urology. 2023;172:157-164.
    PubMed         Abstract available
    
    
69. DOPPALAPUDI SK, Chua KJ, Tabakin AL, Park JH, et al
    Chemotherapy Refractory Spindle-Cell Rhabdomyosarcoma of the Bladder Treated with Consolidative Ovarian-Sparing Radical Surgery.
    Urology. 2022 Nov 16:S0090-4295(22)00953-0. doi: 10.1016/j.urology.2022.
    PubMed         Abstract available
    
    

    
    Zhonghua Zhong Liu Za Zhi

70. ZHONG SJ, Gao JJ, Tang P, Liu YP, et al
    [The efficacy of radiotherapy based combined therapy for unresectable locally invasive bladder cancer and its associated factors analysis].
    Zhonghua Zhong Liu Za Zhi. 2023;45:175-181.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: